Cargando…
Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study
Neurodegenerative disorders involve various pathophysiological pathways, and finding a solution for these issues is still an uphill task for the scientific community. In the present study, a combination of molecular docking and dynamics approaches was applied to target different pathways leading to...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141571/ https://www.ncbi.nlm.nih.gov/pubmed/35626478 http://dx.doi.org/10.3390/e24050593 |
_version_ | 1784715377632083968 |
---|---|
author | Iqbal, Danish Rizvi, Syed Mohd Danish Rehman, Md Tabish Khan, M. Salman Bin Dukhyil, Abdulaziz AlAjmi, Mohamed F. Alshehri, Bader Mohammed Banawas, Saeed Zia, Qamar Alsaweed, Mohammed Madkhali, Yahya Alsagaby, Suliman A. Alturaiki, Wael |
author_facet | Iqbal, Danish Rizvi, Syed Mohd Danish Rehman, Md Tabish Khan, M. Salman Bin Dukhyil, Abdulaziz AlAjmi, Mohamed F. Alshehri, Bader Mohammed Banawas, Saeed Zia, Qamar Alsaweed, Mohammed Madkhali, Yahya Alsagaby, Suliman A. Alturaiki, Wael |
author_sort | Iqbal, Danish |
collection | PubMed |
description | Neurodegenerative disorders involve various pathophysiological pathways, and finding a solution for these issues is still an uphill task for the scientific community. In the present study, a combination of molecular docking and dynamics approaches was applied to target different pathways leading to neurodegenerative disorders such as Alzheimer’s disease. Initially, abrineurin natural inducers were screened using physicochemical properties and toxicity assessment. Out of five screened compounds, a pentacyclic triterpenoid, i.e., Soyasapogenol B appeared to be the most promising after molecular docking and simulation analysis. Soyasapogenol B showed low TPSA (60.69), high absorption (82.6%), no Lipinski rule violation, and no toxicity. Docking interaction analysis revealed that Soyasapogenol B bound effectively to all of the targeted proteins (AChE, BuChE MAO-A, MAO-B, GSK3β, and NMDA), in contrast to other screened abrineurin natural inducers and inhibitors. Importantly, Soyasapogenol B bound to active site residues of the targeted proteins in a similar pattern to the native ligand inhibitor. Further, 100 ns molecular dynamics simulations analysis showed that Soyasapogenol B formed stable complexes against all of the targeted proteins. RMSD analysis showed that the Soyasapogenol B–protein complex exhibited average RMSD values of 1.94 Å, 2.11 Å, 5.07 Å, 2.56 Å, 3.83 Å and 4.07 Å. Furthermore, the RMSF analysis and secondary structure analysis also indicated the stability of the Soyasapogenol B–protein complexes. |
format | Online Article Text |
id | pubmed-9141571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91415712022-05-28 Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study Iqbal, Danish Rizvi, Syed Mohd Danish Rehman, Md Tabish Khan, M. Salman Bin Dukhyil, Abdulaziz AlAjmi, Mohamed F. Alshehri, Bader Mohammed Banawas, Saeed Zia, Qamar Alsaweed, Mohammed Madkhali, Yahya Alsagaby, Suliman A. Alturaiki, Wael Entropy (Basel) Article Neurodegenerative disorders involve various pathophysiological pathways, and finding a solution for these issues is still an uphill task for the scientific community. In the present study, a combination of molecular docking and dynamics approaches was applied to target different pathways leading to neurodegenerative disorders such as Alzheimer’s disease. Initially, abrineurin natural inducers were screened using physicochemical properties and toxicity assessment. Out of five screened compounds, a pentacyclic triterpenoid, i.e., Soyasapogenol B appeared to be the most promising after molecular docking and simulation analysis. Soyasapogenol B showed low TPSA (60.69), high absorption (82.6%), no Lipinski rule violation, and no toxicity. Docking interaction analysis revealed that Soyasapogenol B bound effectively to all of the targeted proteins (AChE, BuChE MAO-A, MAO-B, GSK3β, and NMDA), in contrast to other screened abrineurin natural inducers and inhibitors. Importantly, Soyasapogenol B bound to active site residues of the targeted proteins in a similar pattern to the native ligand inhibitor. Further, 100 ns molecular dynamics simulations analysis showed that Soyasapogenol B formed stable complexes against all of the targeted proteins. RMSD analysis showed that the Soyasapogenol B–protein complex exhibited average RMSD values of 1.94 Å, 2.11 Å, 5.07 Å, 2.56 Å, 3.83 Å and 4.07 Å. Furthermore, the RMSF analysis and secondary structure analysis also indicated the stability of the Soyasapogenol B–protein complexes. MDPI 2022-04-23 /pmc/articles/PMC9141571/ /pubmed/35626478 http://dx.doi.org/10.3390/e24050593 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Iqbal, Danish Rizvi, Syed Mohd Danish Rehman, Md Tabish Khan, M. Salman Bin Dukhyil, Abdulaziz AlAjmi, Mohamed F. Alshehri, Bader Mohammed Banawas, Saeed Zia, Qamar Alsaweed, Mohammed Madkhali, Yahya Alsagaby, Suliman A. Alturaiki, Wael Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study |
title | Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study |
title_full | Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study |
title_fullStr | Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study |
title_full_unstemmed | Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study |
title_short | Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study |
title_sort | soyasapogenol-b as a potential multitarget therapeutic agent for neurodegenerative disorders: molecular docking and dynamics study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141571/ https://www.ncbi.nlm.nih.gov/pubmed/35626478 http://dx.doi.org/10.3390/e24050593 |
work_keys_str_mv | AT iqbaldanish soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT rizvisyedmohddanish soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT rehmanmdtabish soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT khanmsalman soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT bindukhyilabdulaziz soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT alajmimohamedf soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT alshehribadermohammed soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT banawassaeed soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT ziaqamar soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT alsaweedmohammed soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT madkhaliyahya soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT alsagabysulimana soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy AT alturaikiwael soyasapogenolbasapotentialmultitargettherapeuticagentforneurodegenerativedisordersmoleculardockinganddynamicsstudy |